June 26, 2009

SEBI denies Takeover Exemption to Futuristic Garments


Securities and Exchange Board of India (“SEBI”) has by its order dated June 16, 2009, rejected the application (“Exemption Application”) made by the promoters of Surya Pharmaceutical Ltd. (“Target”) seeking an exemption from complying with the mandatory open offer1 requirement under Regulations 10, 11 and 12 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 (“Takeover Code”)2.

Background & Facts

The promoters of the Target along with one of their group entities viz. Futuristic Garments Private Limited (“Acquirer”)3, were holding an aggregate of 35.15% equity stake in the Target. The Target had entered into an arrangement with Industrial Development Bank of India (“IDBI”) for IDBI to provide financial assistance by way of both fund based and non fund based loan to the tune of Rs. 380 million to the Target. As per the terms of the loan arrangement the promoters were required to maintain atleast 51% shareholding in the Target till the subsistence of the loan.

Accordingly, the Target sought to issue 4,700,000 zero coupon optionally convertible share warrants (“Convertible Warrants”) to the Acquirer. The Convertible Warrants were convertible into equity shares over a period of eighteen (18) months and upon conversion would consequently increase the equity stake of the promoters in the Target to 51.05%.4

The Exemption Application made to SEBI was based on the following grounds:

a.     The new issuance and resultant increase in the equity stake would not amount to change in control of management of the Target.


b.    The increase in shareholding is proposed pursuant to the condition imposed by IDBI for sanctioning the loan and the Target would be able to run its business more effectively by raising such additional capital.


c.     The conditions of the stock market are not congenial to make an open offer at ‘this time’ due to volatility.


Recommendations / observation of the Takeover Panel5 on the Exemption Application

Based on the analysis of the Exemption Application, the SEBI Takeover Panel observed the following:


  • The Target had in one of their emails addressed to SEBI stated that if an exemption is granted by SEBI for the preferential allotment, the Target shall be able to bring in about Rs. 340 million and therefore the financial assistance by IDBI may not be required immediately. Hence, the contention of the promoters to maintain the equity stake at 51% pursuant to the financing covenants of IDBI may not be relevant.


  • Such exemption for preferential allotment may be granted in extraordinary events like company becoming sick or infusion of funds by the promoters pursuant to corporate debt restructuring scheme6.  However, the current case may not warrant such an exemption.

Accordingly, granting of such exemption was not favoured by the Takeover Panel.

Submissions by the Acquirer

The following submissions were made by the Target to SEBI subsequent to the recommendations of the Takeover Panel:7


1.     The financial assistance from IDBI was still imperative for the Target and the language in the aforesaid email did not convey the message correctly. Further, IDBI has indicated continued interest in the status of the enhancement of promoter’s stake for disbursement of financial assistance.


2.     The Target was in dire need of financial assistance and hence SEBI should consider the Exemption Application favorably rather than waiting for the Target to become sick for want of funds and then to consider the Exemption application.


SEBI Order:


Subsequent to the recommendation by the Takeover Panel and the submission by the promoters, SEBI rejected the Exemption Application and directed the Acquirer to comply with the open offer requirement under Regulation 11(1) of the Takeover Code on the following grounds:


  • The acquisition of shares through preferential allotment is not exempted automatically from the applicability of the Takeover Code. Such exemptions under the residual Regulation 3(1)(l) of the Takeover Code may be granted in few instances like the company becoming sick or infusion of funds by the promoters / acquirers under the corporate debt restructuring mechanism and the current case does not warrant such exemption. 

  • The contention that the condition of the stock market was not good for an open offer may not have much substance as the shareholders of the Target may want to dispose off their shareholding even in such a market.


  • The submissions of the Acquirer and the grounds for seeking an exemption under the Takeover Code are not convincing enough. Further, considering that there is around 65% public shareholding in the Company, granting of an exemption would deny an exit option to such large base of public shareholders and it would be adverse to their interest.



Though there exists an enabling provision under the Takeover Code authorizing SEBI to grant exemptions from the provisions of these regulations, such powers are very judicially exercised by SEBI. The exemptions granted in the past under this provision have been sparse to include only exceptional situations like increase in the shareholding pursuant to buy back of shares or infusion of fresh capital pursuant to scheme for debt reorganization with the banks and financial institutions. An exemption from the open offer requirement by SEBI in the current case could have resulted in large number of promoters applying for similar exemptions from Takeover Code to hike their stake in the company without providing an exit opportunity to the public shareholders.


1 Regulation 21 - Open offer to acquire an additional 20% voting capital (equity shares) from the shareholders

2 The said application was made by the Target Company on behalf of the promoter under Regulation 3(1)(l) read with Regulation 4(2) of the Takeover Code

3 Existing shareholding of the Acquirer was 3.65%

4 This would result in the increase in equity stake of the promoters by 15.9%


5 Takeover Panel is a panel constituted by SEBI to make a recommendation on whether exemption from open offer requirement can be given to a particular case


6 Under this mechanism the lenders viz. banks and financial institutions and borrowers agree on a scheme of restructuring or repackaging their debts. The said restructuring may take various forms including extending the repayment period, reducing rate of interest, infusion of further funds by the promoters, conversion of interest due into capital, etc.


7 As a process, SEBI shall afford the applicant an opportunity of being heard before passing its order based on the facts of the case and recommendation by the Takeover Panel


 Team M&A
Sahil Shah / Vaidhyanadhan Iyer / Nishchal Joshipura
You can direct your queries or comments to the team


You are welcome to connect with us at interesting conferences, seminars and events (more...

Nishith Desai on Vodafone v/s Tax Department
Vyapak Desai on Foreign Investment Policy
Nishchal Joshipura on Satyam Maytas deal
Vyapak Desai on FII, FDI norms
Kartik Ganapathy on Ranbaxy Daiichi deal
Nishith Desai on Vodafone Controversy
Siddharth Shah on New FDI Norms
Siddharth Shah on P Notes
HCL – Axon Deal Dissected, December 19, 2008
Zandu - Emami Hostile Turned Friendly M&A Deal Dissected, December 3, 2008
Ranbaxy - Daiichi Deal Dissected, November 14, 2008
FCCB buybacks: Is the move enough? The Economic Times, Ruchir Sinha & Nishchal Joshipura, January 6, 2009
Current Laws are adequate to handle this, DNA, R Vaidhyanadhan Iyer, January 1, 2009
Dual listed M&As: Live-in status in corporate world, The Economic Times, R Vaidhyanadhan Iyer & Vedant Shukla, December 17, 2008
SEBI goes the distance in easing takeover regulations, The Economic Times, Ruchir Sinha & Nishchal Joshipura, November 11, 2008
Is it time to bid adieu to ‘poison pills’? The Economic Times, R Vaidhyanadhan Iyer & Nishchal Joshipura, May 27, 2008
Amendments To Takeover Code Oversight Or Intended?, November 7, 2008 
Mergers & Acquisitions in India  
Taxation of Derivatives
Discovering Derivatives
eCommerce Taxation in India
Special Economic Zones
BPO Report
India: Structural Strategy
Inversion - The Basic Facts
Venture Capital at Crossroads

Nishith Desai Associates Hotlines update our clients on recent developments that matter.  You may register to receive them by sending us an  email

Corpsec Hotline
Tax Hotline
HR Hotline
iCe Hotline
Annual Budget
FII Hotline
Pharma Update
Infra Update
IP Update
Dispute Resolution Hotline


Disclaimer: The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.

This hotline provides general information existing at the time of preparation. The hotline is intended as a news update and Nishith Desai Associates neither assumes nor accepts any responsibility for any loss arising to any person acting or refraining from acting as a result of any material contained in this hotline. It is recommended that professional advice be taken based on the specific facts and circumstances. This hotline does not substitute the need to refer to the original pronouncements.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.